Alterity Therapeutics (FRA:PBN) FCF Margin %: 0.00% (As of Dec. 2025)


FRA:PBN Alterity Therapeutics Ltd FRA:PBN
27 GF Score
Price €0.34
View Full Analysis

What is Alterity Therapeutics FCF Margin %?

Alterity Therapeutics FRA:PBN +0.60% 27 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates FRA:PBN with a GF Score™ of 27/100. Among 959 Biotechnology companies, Alterity Therapeutics ranks worse than 104275.18% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alterity Therapeutics's Free Cash Flow for the three months ended in Dec. 2025 was €-3.00 Mil. Alterity Therapeutics's Revenue for the three months ended in Dec. 2025 was €0.00 Mil. Therefore, Alterity Therapeutics's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Alterity Therapeutics's current FCF Yield % is -14.28%.

The historical rank and industry rank for Alterity Therapeutics's FCF Margin % or its related term are showing as below:


During the past 13 years, the highest FCF Margin % of Alterity Therapeutics was -5189.51%. The lowest was -5189.51%. And the median was -5189.51%.

FRA:PBN's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -84.65
* Ranked among companies with meaningful FCF Margin % only.

Alterity Therapeutics FCF Margin % Related Terms

Alterity Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Alterity Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alterity Therapeutics FCF Margin % Chart

Alterity Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Alterity Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:PBN vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Alterity Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alterity Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's FCF Margin % falls into.


FRA:PBN
27GF Score
Alterity Therapeutics Ltd FRA:PBN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alterity Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Alterity Therapeutics's FCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-6.464/0
= %

Alterity Therapeutics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-2.997/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Alterity Therapeutics (FRA:PBN) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alterity Therapeutics and its competitors. According to the industry distribution chart, Alterity Therapeutics ranks #999999 out of 959 companies in the Biotechnology industry.
Is Alterity Therapeutics' FCF Margin % too high?
Alterity Therapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Alterity Therapeutics ranks #999999 out of 959 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alterity Therapeutics has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Alterity Therapeutics' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alterity Therapeutics ranks #999999 out of 959 companies for FCF Margin %. This places Alterity Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Alterity Therapeutics and its competitors. Alterity Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alterity Therapeutics stock overvalued right now?
Alterity Therapeutics (FRA:PBN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Alterity Therapeutics' overall GF Score™ is 27/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Alterity Therapeutics (FRA:PBN), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alterity Therapeutics Business Description

Other Exchanges ATHE:USAATH:Australia
Address 350 Collins Street, Suite 4, Level 14, Melbourne, VIC, AUS, 3000
Alterity Therapeutics Ltd is a clinical-stage biotechnology company focused on neurodegenerative diseases and the creation of a chemical library of proprietary molecules. Its research and clinical development efforts are focused on Parkinson's disease and related disorders, where it is identifying and developing novel compounds that address the underlying pathology of these disorders by binding and redistributing excess labile iron, reducing alpha-synuclein aggregation, and rescuing neurons in the brain. Its pipeline programs are ATH434-201, ATH434-202, bioMUSE, ATH434, and Drug Discovery. The Group operated in one segment, research and development into Parkinsonian and other neurodegenerative disorders.
27GF Score

Get the complete analysis for FRA:PBN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.34
Price